ID

35516

Description

Study ID: 101468/194 Clinical Study ID: 101468/194 Study Title: A 12 Week, Double-Blind, Placebo-Controlled, Parallel Group Study to Assess the Efficacy and Safety of Ropinirole in Patients Suffering from Restless Legs Syndrome (RLS). Patient Level Data: Study Listed on ClinicalStudyDataRequest.com Clinicaltrials.gov Identifier: Sponsor: GlaxoSmithKline Collaborators: N/A Phase: phase 3 Study Recruitment Status: Completed Generic Name: ropinirole Trade Name: requip Study Indication: Restless Legs Syndrome

Mots-clés

Versions (1)
  1. 06/03/2019 06/03/2019 -
Détendeur de droits

GlaxoSmithKline

Téléchargé le

6 mars 2019

DOI

Pour une demande vous connecter.

Licence

Creative Commons BY-NC 3.0
Modèle Commentaires :

Ici, vous pouvez faire des commentaires sur le modèle. À partir des bulles de texte, vous pouvez laisser des commentaires spécifiques sur les groupes Item et les Item.

Retour au modèle Commentaires
Groupe Item commentaires pour :

Item commentaires pour :

  • Plus récent
  • Plus ancien
  • Favori
  • Plus récent
    • Plus récent
    • Plus ancien
    • Favori

Aucun commentaire

Vous devez être connecté pour pouvoir télécharger des formulaires. Veuillez vous connecter ou s’inscrire gratuitement.

Ropinirole in Patients with Restless Legs Syndrome (Study ID: 101468/194)

Anglais

Study Medication and Compliance Record

1 Formulaires  
Administrative data
Description

Administrative data

Alias
UMLS CUI-1
C1320722
Centre Number
Description

Study Coordinating Center, Identification number

Type de données

integer

Alias
UMLS CUI [1,1]
C2825181
UMLS CUI [1,2]
C1300638
Patient Number
Description

Clinical Trial Subject Unique Identifier

Type de données

integer

Alias
UMLS CUI [1]
C2348585
Patient Initials
Description

Person Initials

Type de données

text

Alias
UMLS CUI [1]
C2986440
Study Medication Record
Description

Study Medication Record

Alias
UMLS CUI-1
C0304229
UMLS CUI-2
C2734539
Study Med. Week No.
Description

Experimental drug, Week, Numbers

Type de données

text

Alias
UMLS CUI [1,1]
C0304229
UMLS CUI [1,2]
C0439230
UMLS CUI [1,3]
C0237753
Is this a Dose Reduction?
Description

if ’No’, continue if ’Yes’, please complete theDose Reductions due to AE on page 64. Do not continue on this page for this visit.

Type de données

boolean

Alias
UMLS CUI [1,1]
C0304229
UMLS CUI [1,2]
C1707814
Dose Level (Specify 1 - 8)
Description

Experimental drug, Dosage, Level

Type de données

integer

Alias
UMLS CUI [1,1]
C0304229
UMLS CUI [1,2]
C0178602
UMLS CUI [1,3]
C0441889
Date First Dose
Description

Experimental drug, Medication dose, Start Date

Type de données

date

Alias
UMLS CUI [1,1]
C0304229
UMLS CUI [1,2]
C3174092
UMLS CUI [1,3]
C0808070
Date Last Dose
Description

Experimental drug, Date last dose

Type de données

date

Alias
UMLS CUI [1,1]
C0304229
UMLS CUI [1,2]
C1762893
Number of tablets dispensed
Description

Experimental Drug, Dispensed Amount

Type de données

integer

Alias
UMLS CUI [1,1]
C0805077
UMLS CUI [1,2]
C0805077
Number of tablets returned
Description

Experimental drug, Returned Amount

Type de données

integer

Alias
UMLS CUI [1,1]
C2699071
UMLS CUI [1,2]
C2699071
Interruption of ≥ 2 consecutive days?
Description

Experimental drug, Interruption

Type de données

boolean

Alias
UMLS CUI [1,1]
C0304229
UMLS CUI [1,2]
C1512900
Medication Labels
Description

Experimental Drug, Drug Labeling

Type de données

text

Alias
UMLS CUI [1,1]
C0304229
UMLS CUI [1,2]
C0013191
Dose Reduction Due to Adverse Experiences
Description

Dose Reduction Due to Adverse Experiences

Alias
UMLS CUI-1
C0304229
UMLS CUI-2
C1707814
UMLS CUI-3
C0877248
Study Med. Week No.
Description

Experimental drug, Dose Reduced, Adverse Event, Week, Numbers

Type de données

text

Alias
UMLS CUI [1,1]
C0304229
UMLS CUI [1,2]
C1707814
UMLS CUI [1,3]
C0877248
UMLS CUI [1,4]
C0439230
UMLS CUI [1,5]
C0237753
Dose Level (Specify 1 - 8)
Description

Experimental drug, Dose Reduced, Adverse Event, Dosage, Level

Type de données

integer

Alias
UMLS CUI [1,1]
C0304229
UMLS CUI [1,2]
C1707814
UMLS CUI [1,3]
C0877248
UMLS CUI [1,4]
C0178602
UMLS CUI [1,5]
C0441889
Date First Dose
Description

Experimental drug, Dose Reduced, Adverse Event, Medication dose, Start Date

Type de données

date

Alias
UMLS CUI [1,1]
C0304229
UMLS CUI [1,2]
C1707814
UMLS CUI [1,3]
C0877248
UMLS CUI [1,4]
C3174092
UMLS CUI [1,5]
C0808070
Date Last Dose
Description

Experimental drug, Dose Reduced, Adverse Event, Date last dose

Type de données

date

Alias
UMLS CUI [1,1]
C0304229
UMLS CUI [1,2]
C1707814
UMLS CUI [1,3]
C0877248
UMLS CUI [1,4]
C1762893
Number of tablets dispensed
Description

Experimental Drug, Dose Reduced, Adverse Event, Dispensed Amount

Type de données

integer

Alias
UMLS CUI [1,1]
C0805077
UMLS CUI [1,2]
C1707814
UMLS CUI [1,3]
C0877248
UMLS CUI [1,4]
C0805077
Number of tablets returned
Description

Experimental drug, Dose Reduced, Adverse Event, Returned Amount

Type de données

integer

Alias
UMLS CUI [1,1]
C2699071
UMLS CUI [1,2]
C1707814
UMLS CUI [1,3]
C0877248
UMLS CUI [1,4]
C2699071
Interruption of ≥ 2 consecutive days?
Description

Experimental drug, Dose Reduced, Adverse Event, Interruption

Type de données

boolean

Alias
UMLS CUI [1,1]
C0304229
UMLS CUI [1,2]
C1707814
UMLS CUI [1,3]
C0877248
UMLS CUI [1,4]
C1512900
Medication Labels
Description

Experimental Drug, Dose Reduced, Adverse Event, Drug Labeling

Type de données

text

Alias
UMLS CUI [1,1]
C0304229
UMLS CUI [1,2]
C1707814
UMLS CUI [1,3]
C0877248
UMLS CUI [1,4]
C0013191
Retour au début de la page

Similar models

Study Medication and Compliance Record

1 Formulaires
Name
Type
Description | Question | Decode (Coded Value)
Type de données
Alias
Item Group
Administrative data
C1320722 (UMLS CUI-1)
Study Coordinating Center, Identification number
Item
Centre Number
integer
C2825181 (UMLS CUI [1,1])
C1300638 (UMLS CUI [1,2])
Clinical Trial Subject Unique Identifier
Item
Patient Number
integer
C2348585 (UMLS CUI [1])
Person Initials
Item
Patient Initials
text
C2986440 (UMLS CUI [1])
Item Group
Study Medication Record
C0304229 (UMLS CUI-1)
C2734539 (UMLS CUI-2)
Item
Study Med. Week No.
text
C0304229 (UMLS CUI [1,1])
C0439230 (UMLS CUI [1,2])
C0237753 (UMLS CUI [1,3])
Experimental drug, Week, Numbers
Code List
Study Med. Week No.
CL Item
Wk 1 (Days 1-2) (1)
CL Item
Wk 1 (Days 3-7) (2)
CL Item
Wk 2 (3)
CL Item
Wk 3 (4)
CL Item
Wk 4 (5)
CL Item
Wk 5 (6)
CL Item
Wk 6 (7)
CL Item
Wk 7 (8)
CL Item
Wk 8 (9)
CL Item
Wk 9 (10)
CL Item
Wk 10 (11)
CL Item
Wk 11 (12)
CL Item
Wk 12 (13)
Experimental drug, Dose Reduced
Item
Is this a Dose Reduction?
boolean
C0304229 (UMLS CUI [1,1])
C1707814 (UMLS CUI [1,2])
Experimental drug, Dosage, Level
Item
Dose Level (Specify 1 - 8)
integer
C0304229 (UMLS CUI [1,1])
C0178602 (UMLS CUI [1,2])
C0441889 (UMLS CUI [1,3])
Experimental drug, Medication dose, Start Date
Item
Date First Dose
date
C0304229 (UMLS CUI [1,1])
C3174092 (UMLS CUI [1,2])
C0808070 (UMLS CUI [1,3])
Experimental drug, Date last dose
Item
Date Last Dose
date
C0304229 (UMLS CUI [1,1])
C1762893 (UMLS CUI [1,2])
Experimental Drug, Dispensed Amount
Item
Number of tablets dispensed
integer
C0805077 (UMLS CUI [1,1])
C0805077 (UMLS CUI [1,2])
Experimental drug, Returned Amount
Item
Number of tablets returned
integer
C2699071 (UMLS CUI [1,1])
C2699071 (UMLS CUI [1,2])
Experimental drug, Interruption
Item
Interruption of ≥ 2 consecutive days?
boolean
C0304229 (UMLS CUI [1,1])
C1512900 (UMLS CUI [1,2])
Experimental Drug, Drug Labeling
Item
Medication Labels
text
C0304229 (UMLS CUI [1,1])
C0013191 (UMLS CUI [1,2])
Item Group
Dose Reduction Due to Adverse Experiences
C0304229 (UMLS CUI-1)
C1707814 (UMLS CUI-2)
C0877248 (UMLS CUI-3)
Experimental drug, Dose Reduced, Adverse Event, Week, Numbers
Item
Study Med. Week No.
text
C0304229 (UMLS CUI [1,1])
C1707814 (UMLS CUI [1,2])
C0877248 (UMLS CUI [1,3])
C0439230 (UMLS CUI [1,4])
C0237753 (UMLS CUI [1,5])
Experimental drug, Dose Reduced, Adverse Event, Dosage, Level
Item
Dose Level (Specify 1 - 8)
integer
C0304229 (UMLS CUI [1,1])
C1707814 (UMLS CUI [1,2])
C0877248 (UMLS CUI [1,3])
C0178602 (UMLS CUI [1,4])
C0441889 (UMLS CUI [1,5])
Experimental drug, Dose Reduced, Adverse Event, Medication dose, Start Date
Item
Date First Dose
date
C0304229 (UMLS CUI [1,1])
C1707814 (UMLS CUI [1,2])
C0877248 (UMLS CUI [1,3])
C3174092 (UMLS CUI [1,4])
C0808070 (UMLS CUI [1,5])
Experimental drug, Dose Reduced, Adverse Event, Date last dose
Item
Date Last Dose
date
C0304229 (UMLS CUI [1,1])
C1707814 (UMLS CUI [1,2])
C0877248 (UMLS CUI [1,3])
C1762893 (UMLS CUI [1,4])
Experimental Drug, Dose Reduced, Adverse Event, Dispensed Amount
Item
Number of tablets dispensed
integer
C0805077 (UMLS CUI [1,1])
C1707814 (UMLS CUI [1,2])
C0877248 (UMLS CUI [1,3])
C0805077 (UMLS CUI [1,4])
Experimental drug, Dose Reduced, Adverse Event, Returned Amount
Item
Number of tablets returned
integer
C2699071 (UMLS CUI [1,1])
C1707814 (UMLS CUI [1,2])
C0877248 (UMLS CUI [1,3])
C2699071 (UMLS CUI [1,4])
Experimental drug, Dose Reduced, Adverse Event, Interruption
Item
Interruption of ≥ 2 consecutive days?
boolean
C0304229 (UMLS CUI [1,1])
C1707814 (UMLS CUI [1,2])
C0877248 (UMLS CUI [1,3])
C1512900 (UMLS CUI [1,4])
Experimental Drug, Dose Reduced, Adverse Event, Drug Labeling
Item
Medication Labels
text
C0304229 (UMLS CUI [1,1])
C1707814 (UMLS CUI [1,2])
C0877248 (UMLS CUI [1,3])
C0013191 (UMLS CUI [1,4])
Retour au début de la page 

Aide

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial